• Something wrong with this record ?

FasL Modulates Expression of Mmp2 in Osteoblasts

E. Svandova, B. Vesela, H. Lesot, J. Sadoine, A. Poliard, E. Matalova,

. 2018 ; 9 (-) : 1314. [pub] 20180919

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19001673

FasL is a well-known actor in the apoptotic pathways but recent reports have pointed to its important novel roles beyond cell death, as observed also for bone cells. This is supported by non-apoptotic appearance of FasL during osteogenesis and by significant bone alterations unrelated to apoptosis in FasL deficient (gld) mice. The molecular mechanism behind this novel role has not yet been revealed. In this report, intramembranous bone, where osteoblasts differentiate directly from mesenchymal precursors without intermediary chondrogenic step, was investigated. Mouse mandibular bone surrounding the first lower molar was used as a model. The stage where a complex set of bone cells (osteoblasts, osteocytes, osteoclasts) is first present during development was selected for an initial examination. Immunohistochemical staining detected FasL in non-apoptotic cells at this stage. Further, FasL deficient vs. wild type samples subjected to osteogenic PCR Array analysis displayed a significantly decreased expression of Mmp2 in gld bone. To examine the possibility of this novel FasL-Mmp2 relationship, intramembranous bone-derived osteoblastic cells (MC3T3-E1) were treated with anti-FasL antibody or rmFasL. Indeed, the FasL neutralization caused a decreased expression of Mmp2 and rmFasL added to the cells resulted in the opposite effect. Since Mmp2-/- mice display age-dependent alterations in the intramembranous bone, early stages of gld mandibular bone were examined and age-dependent phenotype was confirmed also in gld mice. Taken together, the present in vivo and in vitro findings point to a new non-apoptotic function of FasL in bone development associated with Mmp2 expression.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19001673
003      
CZ-PrNML
005      
20190109122326.0
007      
ta
008      
190107s2018 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fphys.2018.01314 $2 doi
035    __
$a (PubMed)30283358
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Svandova, Eva $u Department of Physiology, University of Veterinary and Pharmaceutical Sciences, Brno, Czechia. Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics, The Czech Academy of Sciences, Brno, Czechia.
245    10
$a FasL Modulates Expression of Mmp2 in Osteoblasts / $c E. Svandova, B. Vesela, H. Lesot, J. Sadoine, A. Poliard, E. Matalova,
520    9_
$a FasL is a well-known actor in the apoptotic pathways but recent reports have pointed to its important novel roles beyond cell death, as observed also for bone cells. This is supported by non-apoptotic appearance of FasL during osteogenesis and by significant bone alterations unrelated to apoptosis in FasL deficient (gld) mice. The molecular mechanism behind this novel role has not yet been revealed. In this report, intramembranous bone, where osteoblasts differentiate directly from mesenchymal precursors without intermediary chondrogenic step, was investigated. Mouse mandibular bone surrounding the first lower molar was used as a model. The stage where a complex set of bone cells (osteoblasts, osteocytes, osteoclasts) is first present during development was selected for an initial examination. Immunohistochemical staining detected FasL in non-apoptotic cells at this stage. Further, FasL deficient vs. wild type samples subjected to osteogenic PCR Array analysis displayed a significantly decreased expression of Mmp2 in gld bone. To examine the possibility of this novel FasL-Mmp2 relationship, intramembranous bone-derived osteoblastic cells (MC3T3-E1) were treated with anti-FasL antibody or rmFasL. Indeed, the FasL neutralization caused a decreased expression of Mmp2 and rmFasL added to the cells resulted in the opposite effect. Since Mmp2-/- mice display age-dependent alterations in the intramembranous bone, early stages of gld mandibular bone were examined and age-dependent phenotype was confirmed also in gld mice. Taken together, the present in vivo and in vitro findings point to a new non-apoptotic function of FasL in bone development associated with Mmp2 expression.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vesela, Barbora $u Department of Physiology, University of Veterinary and Pharmaceutical Sciences, Brno, Czechia. Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics, The Czech Academy of Sciences, Brno, Czechia.
700    1_
$a Lesot, Hervé $u Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics, The Czech Academy of Sciences, Brno, Czechia.
700    1_
$a Sadoine, Jeremy $u Faculté de Chirurgie Dentaire, Université Paris Descartes, Paris, France.
700    1_
$a Poliard, Anne $u Faculté de Chirurgie Dentaire, Université Paris Descartes, Paris, France.
700    1_
$a Matalova, Eva $u Department of Physiology, University of Veterinary and Pharmaceutical Sciences, Brno, Czechia. Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics, The Czech Academy of Sciences, Brno, Czechia.
773    0_
$w MED00174601 $t Frontiers in physiology $x 1664-042X $g Roč. 9, č. - (2018), s. 1314
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30283358 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190109122529 $b ABA008
999    __
$a ind $b bmc $g 1365480 $s 1039796
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 9 $c - $d 1314 $e 20180919 $i 1664-042X $m Frontiers in physiology $n Front. physiol. $x MED00174601
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Archiving options